HEADER TRANSFERASE 21-FEB-16 5I9Y TITLE CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE WITH TITLE 2 DASATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPHRIN TYPE-A RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 596-900; COMPND 5 SYNONYM: EPITHELIAL CELL KINASE,TYROSINE-PROTEIN KINASE RECEPTOR ECK; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EPHA2, ECK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS TRANSFERASE, TYROSINE-PROTEIN KINASE, RECEPTOR, ATP-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR D.KUDLINZKI,V.L.LINHARD,S.L.GANDE,S.SREERAMULU,K.SAXENA,S.HEINZLMEIR, AUTHOR 2 G.MEDARD,B.KUESTER,H.SCHWALBE REVDAT 7 10-JAN-24 5I9Y 1 REMARK REVDAT 6 12-JUN-19 5I9Y 1 AUTHOR REVDAT 5 03-APR-19 5I9Y 1 SOURCE REVDAT 4 07-MAR-18 5I9Y 1 SOURCE REMARK REVDAT 3 28-DEC-16 5I9Y 1 JRNL REVDAT 2 14-DEC-16 5I9Y 1 JRNL REVDAT 1 09-NOV-16 5I9Y 0 JRNL AUTH S.HEINZLMEIR,D.KUDLINZKI,S.SREERAMULU,S.KLAEGER,S.L.GANDE, JRNL AUTH 2 V.LINHARD,M.WILHELM,H.QIAO,D.HELM,B.RUPRECHT,K.SAXENA, JRNL AUTH 3 G.MEDARD,H.SCHWALBE,B.KUSTER JRNL TITL CHEMICAL PROTEOMICS AND STRUCTURAL BIOLOGY DEFINE EPHA2 JRNL TITL 2 INHIBITION BY CLINICAL KINASE DRUGS. JRNL REF ACS CHEM. BIOL. V. 11 3400 2016 JRNL REFN ESSN 1554-8937 JRNL PMID 27768280 JRNL DOI 10.1021/ACSCHEMBIO.6B00709 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.L.GANDE,K.SAXENA,S.SREERAMULU,V.LINHARD,D.KUDLINZKI, REMARK 1 AUTH 2 S.HEINZLMEIR,A.J.REICHERT,A.SKERRA,B.KUSTER,H.SCHWALBE REMARK 1 TITL EXPRESSION AND PURIFICATION OF EPHA2 TYROSINE KINASE DOMAIN REMARK 1 TITL 2 FOR CRYSTALLOGRAPHIC AND NMR STUDIES. REMARK 1 REF CHEMBIOCHEM V. 17 2257 2016 REMARK 1 REFN ESSN 1439-7633 REMARK 1 PMID 27685543 REMARK 1 DOI 10.1002/CBIC.201600483 REMARK 2 REMARK 2 RESOLUTION. 1.23 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.23 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.320 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 147417 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.164 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.180 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 7379 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.4416 - 3.8139 0.99 4800 254 0.1592 0.1584 REMARK 3 2 3.8139 - 3.0275 0.99 4768 253 0.1473 0.1782 REMARK 3 3 3.0275 - 2.6450 0.98 4772 254 0.1594 0.1767 REMARK 3 4 2.6450 - 2.4032 0.99 4755 250 0.1563 0.1800 REMARK 3 5 2.4032 - 2.2309 0.99 4829 259 0.1563 0.1646 REMARK 3 6 2.2309 - 2.0994 0.99 4820 253 0.1474 0.1745 REMARK 3 7 2.0994 - 1.9943 0.98 4787 253 0.1553 0.1645 REMARK 3 8 1.9943 - 1.9075 0.99 4759 249 0.1529 0.1594 REMARK 3 9 1.9075 - 1.8340 0.99 4784 250 0.1517 0.1514 REMARK 3 10 1.8340 - 1.7708 0.99 4808 254 0.1555 0.1894 REMARK 3 11 1.7708 - 1.7154 0.99 4775 256 0.1593 0.1964 REMARK 3 12 1.7154 - 1.6664 0.98 4825 252 0.1696 0.1865 REMARK 3 13 1.6664 - 1.6225 0.98 4731 252 0.1664 0.1853 REMARK 3 14 1.6225 - 1.5829 0.98 4769 252 0.1626 0.1911 REMARK 3 15 1.5829 - 1.5469 0.98 4773 252 0.1600 0.1865 REMARK 3 16 1.5469 - 1.5140 0.98 4778 254 0.1669 0.1894 REMARK 3 17 1.5140 - 1.4837 0.98 4739 250 0.1667 0.1574 REMARK 3 18 1.4837 - 1.4557 0.98 4776 252 0.1602 0.1598 REMARK 3 19 1.4557 - 1.4297 0.98 4748 249 0.1726 0.1778 REMARK 3 20 1.4297 - 1.4055 0.97 4742 250 0.1816 0.1890 REMARK 3 21 1.4055 - 1.3828 0.97 4758 248 0.1833 0.2326 REMARK 3 22 1.3828 - 1.3615 0.98 4670 242 0.1930 0.1796 REMARK 3 23 1.3615 - 1.3415 0.97 4800 252 0.1901 0.2135 REMARK 3 24 1.3415 - 1.3226 0.98 4710 250 0.1934 0.1994 REMARK 3 25 1.3226 - 1.3047 0.97 4669 243 0.2085 0.2179 REMARK 3 26 1.3047 - 1.2878 0.97 4794 252 0.2098 0.2308 REMARK 3 27 1.2878 - 1.2717 0.96 4529 238 0.2257 0.2456 REMARK 3 28 1.2717 - 1.2564 0.89 4391 231 0.2336 0.2669 REMARK 3 29 1.2564 - 1.2418 0.80 3928 201 0.2445 0.2672 REMARK 3 30 1.2418 - 1.2278 0.68 3251 174 0.2585 0.2783 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2545 REMARK 3 ANGLE : 1.041 3444 REMARK 3 CHIRALITY : 0.082 360 REMARK 3 PLANARITY : 0.005 441 REMARK 3 DIHEDRAL : 19.146 1005 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5I9Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000217941. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, EMBL C/O DESY REMARK 200 BEAMLINE : P13 (MX1) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 147422 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.228 REMARK 200 RESOLUTION RANGE LOW (A) : 38.423 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 3.350 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.23 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.30 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1MQB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 37.5 % MPD_P1K_P3350, 0.1 M REMARK 280 AMINOACIDSMIX, 0.1 M HEPES PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 53.82100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 595 REMARK 465 ASP A 596 REMARK 465 PRO A 597 REMARK 465 ASN A 598 REMARK 465 GLN A 599 REMARK 465 SER A 635 REMARK 465 SER A 636 REMARK 465 GLY A 637 REMARK 465 THR A 773 REMARK 465 THR A 774 REMARK 465 SER A 775 REMARK 465 GLY A 776 REMARK 465 GLY A 777 REMARK 465 LYS A 778 REMARK 465 ILE A 779 REMARK 465 SER A 897 REMARK 465 THR A 898 REMARK 465 SER A 899 REMARK 465 GLY A 900 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1201 O HOH A 1318 2.10 REMARK 500 O HOH A 1103 O HOH A 1275 2.16 REMARK 500 O GLY A 622 O HOH A 1101 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1275 O HOH A 1347 1455 2.13 REMARK 500 O HOH A 1178 O HOH A 1245 1554 2.15 REMARK 500 O HOH A 1157 O HOH A 1338 1455 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 738 -16.24 76.83 REMARK 500 SER A 756 -158.38 -124.31 REMARK 500 ASP A 757 77.74 73.14 REMARK 500 ASP A 757 77.74 58.31 REMARK 500 LEU A 760 -111.35 -98.87 REMARK 500 TRP A 819 -130.54 54.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1N1 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1004 DBREF 5I9Y A 596 900 UNP P29317 EPHA2_HUMAN 596 900 SEQADV 5I9Y GLY A 595 UNP P29317 EXPRESSION TAG SEQRES 1 A 306 GLY ASP PRO ASN GLN ALA VAL LEU LYS PHE THR THR GLU SEQRES 2 A 306 ILE HIS PRO SER CYS VAL THR ARG GLN LYS VAL ILE GLY SEQRES 3 A 306 ALA GLY GLU PHE GLY GLU VAL TYR LYS GLY MET LEU LYS SEQRES 4 A 306 THR SER SER GLY LYS LYS GLU VAL PRO VAL ALA ILE LYS SEQRES 5 A 306 THR LEU LYS ALA GLY TYR THR GLU LYS GLN ARG VAL ASP SEQRES 6 A 306 PHE LEU GLY GLU ALA GLY ILE MET GLY GLN PHE SER HIS SEQRES 7 A 306 HIS ASN ILE ILE ARG LEU GLU GLY VAL ILE SER LYS TYR SEQRES 8 A 306 LYS PRO MET MET ILE ILE THR GLU TYR MET GLU ASN GLY SEQRES 9 A 306 ALA LEU ASP LYS PHE LEU ARG GLU LYS ASP GLY GLU PHE SEQRES 10 A 306 SER VAL LEU GLN LEU VAL GLY MET LEU ARG GLY ILE ALA SEQRES 11 A 306 ALA GLY MET LYS TYR LEU ALA ASN MET ASN TYR VAL HIS SEQRES 12 A 306 ARG ASP LEU ALA ALA ARG ASN ILE LEU VAL ASN SER ASN SEQRES 13 A 306 LEU VAL CYS LYS VAL SER ASP PHE GLY LEU SER ARG VAL SEQRES 14 A 306 LEU GLU ASP ASP PRO GLU ALA THR TYR THR THR SER GLY SEQRES 15 A 306 GLY LYS ILE PRO ILE ARG TRP THR ALA PRO GLU ALA ILE SEQRES 16 A 306 SER TYR ARG LYS PHE THR SER ALA SER ASP VAL TRP SER SEQRES 17 A 306 PHE GLY ILE VAL MET TRP GLU VAL MET THR TYR GLY GLU SEQRES 18 A 306 ARG PRO TYR TRP GLU LEU SER ASN HIS GLU VAL MET LYS SEQRES 19 A 306 ALA ILE ASN ASP GLY PHE ARG LEU PRO THR PRO MET ASP SEQRES 20 A 306 CYS PRO SER ALA ILE TYR GLN LEU MET MET GLN CYS TRP SEQRES 21 A 306 GLN GLN GLU ARG ALA ARG ARG PRO LYS PHE ALA ASP ILE SEQRES 22 A 306 VAL SER ILE LEU ASP LYS LEU ILE ARG ALA PRO ASP SER SEQRES 23 A 306 LEU LYS THR LEU ALA ASP PHE ASP PRO ARG VAL SER ILE SEQRES 24 A 306 ARG LEU PRO SER THR SER GLY HET 1N1 A1001 66 HET EDO A1002 4 HET EDO A1003 4 HET EDO A1004 4 HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL) HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3- HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN 1N1 DASATINIB HETSYN EDO ETHYLENE GLYCOL FORMUL 2 1N1 C22 H26 CL N7 O2 S FORMUL 3 EDO 3(C2 H6 O2) FORMUL 6 HOH *290(H2 O) HELIX 1 AA1 ALA A 600 THR A 605 5 6 HELIX 2 AA2 HIS A 609 SER A 611 5 3 HELIX 3 AA3 THR A 653 GLY A 668 1 16 HELIX 4 AA4 LEU A 700 LYS A 707 1 8 HELIX 5 AA5 SER A 712 MET A 733 1 22 HELIX 6 AA6 ALA A 741 ARG A 743 5 3 HELIX 7 AA7 SER A 761 ASP A 767 1 7 HELIX 8 AA8 PRO A 780 THR A 784 5 5 HELIX 9 AA9 ALA A 785 ARG A 792 1 8 HELIX 10 AB1 THR A 795 THR A 812 1 18 HELIX 11 AB2 SER A 822 ASP A 832 1 11 HELIX 12 AB3 PRO A 843 TRP A 854 1 12 HELIX 13 AB4 GLU A 857 ARG A 861 5 5 HELIX 14 AB5 LYS A 863 ALA A 877 1 15 HELIX 15 AB6 PRO A 878 THR A 883 5 6 SHEET 1 AA1 5 VAL A 613 ALA A 621 0 SHEET 2 AA1 5 GLU A 626 LEU A 632 -1 O VAL A 627 N ILE A 619 SHEET 3 AA1 5 VAL A 641 LEU A 648 -1 O ILE A 645 N TYR A 628 SHEET 4 AA1 5 MET A 688 GLU A 693 -1 O ILE A 690 N LYS A 646 SHEET 5 AA1 5 LEU A 678 ILE A 682 -1 N GLY A 680 O ILE A 691 SHEET 1 AA2 3 GLY A 698 ALA A 699 0 SHEET 2 AA2 3 ILE A 745 VAL A 747 -1 O VAL A 747 N GLY A 698 SHEET 3 AA2 3 CYS A 753 VAL A 755 -1 O LYS A 754 N LEU A 746 CISPEP 1 LYS A 686 PRO A 687 0 1.63 SITE 1 AC1 22 ILE A 619 ALA A 644 ILE A 645 LYS A 646 SITE 2 AC1 22 GLU A 663 MET A 667 ILE A 690 THR A 692 SITE 3 AC1 22 GLU A 693 TYR A 694 MET A 695 GLU A 696 SITE 4 AC1 22 GLY A 698 LYS A 702 GLU A 706 LEU A 746 SITE 5 AC1 22 SER A 756 HOH A1111 HOH A1204 HOH A1210 SITE 6 AC1 22 HOH A1280 HOH A1318 SITE 1 AC2 6 ASN A 732 GLU A 815 LYS A 863 PHE A 864 SITE 2 AC2 6 ALA A 865 HOH A1144 SITE 1 AC3 7 ILE A 781 THR A 784 ILE A 789 MET A 827 SITE 2 AC3 7 ILE A 830 HOH A1118 HOH A1121 SITE 1 AC4 6 HIS A 673 ASN A 748 ASN A 750 VAL A 752 SITE 2 AC4 6 LYS A 754 HOH A1186 CRYST1 32.775 107.642 40.661 90.00 109.10 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.030511 0.000000 0.010565 0.00000 SCALE2 0.000000 0.009290 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026026 0.00000